6IO0

Human IDH1 R132C mutant complexed with compound A.

Summary for 6IO0

• Entry DOI: 10.2210/pdb6io0/pdb
• Descriptor: Isocitrate dehydrogenase [NADP] cytoplasmic, (2E)-3-{3-[3-(2,6-dichlorophenyl)-5-(propan-2-yl)-1,2-oxazole-4-carbonyl]-1-methyl-1H-indol-7-yl}prop-2-enoic acid, NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... (6 entities in total)
• Functional Keywords: iso-citrate dehydrogenase, allosteric inhibitor, nadph, oxidoreductase
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 2
• Total formula weight: 97010.90

Authors

Suzuki, M.,Baba, D.,Hanzawa, H. (deposition date: 2018-10-29, release date: 2019-10-30, Last modification date: 2024-03-27)

• Primary citation: Machida, Y.,Nakagawa, M.,Matsunaga, H.,Yamaguchi, M.,Ogawara, Y.,Shima, Y.,Yamagata, K.,Katsumoto, T.,Hattori, A.,Itoh, M.,Seki, T.,Nishiya, Y.,Nakamura, K.,Suzuki, K.,Imaoka, T.,Baba, D.,Suzuki, M.,Sampetrean, O.,Saya, H.,Ichimura, K.,Kitabayashi, I.; A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.; Mol.Cancer Ther., 19:375-383, 2020; PubMed: 31727689; DOI: 10.1158/1535-7163.MCT-18-1349

Experimental method

X-RAY DIFFRACTION (2.2 Å)